-
1
-
-
85028206243
-
-
San Francisco CA: ZDNet; Accessed September 1, 2014
-
Nusca A. After a year of medical school, IBM's Watson passes first milestone. San Francisco, CA: ZDNet; 2013. http://www.zdnet.com/after-a-year-of-medical-school-ibms-watson-passes-first-milestone-7000011062/. Accessed September 1, 2014.
-
(2013)
After A Year of Medical School IBM's Watson Passes First Milestone
-
-
Nusca, A.1
-
2
-
-
34249910647
-
Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease
-
Rocha-Singh KJ, Jaff MR, Crabtree TR, Bloch DA, Ansel G; VIVA Physicians, Inc. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv. 2007;69:910-919.
-
(2007)
Catheter Cardiovasc Interv
, vol.69
, pp. 910-919
-
-
Rocha-Singh, K.J.1
Jaff, M.R.2
Crabtree, T.R.3
Bloch, D.A.4
Ansel, G.5
-
3
-
-
77955881516
-
Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial
-
Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR; RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267-276.
-
(2010)
Circ Cardiovasc Interv
, vol.3
, pp. 267-276
-
-
Laird, J.R.1
Katzen, B.T.2
Scheinert, D.3
Lammer, J.4
Carpenter, J.5
Buchbinder, M.6
Dave, R.7
Ansel, G.8
Lansky, A.9
Cristea, E.10
Collins, T.J.11
Goldstein, J.12
Jaff, M.R.13
-
4
-
-
84906352769
-
Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE le Study
-
McKinsey JF, Zeller T, Rocha-Singh KJ, Jaff MR, Garcia LA; DEFINITIVE LE Investigators. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE Study. JACC Cardiovasc Interv. 2014;7:923-933.
-
(2014)
JACC Cardiovasc Interv
, vol.7
, pp. 923-933
-
-
McKinsey, J.F.1
Zeller, T.2
Rocha-Singh, K.J.3
Jaff, M.R.4
Garcia, L.A.5
-
5
-
-
84878920130
-
Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies
-
Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Snyder SA, O'Leary EE, Tepe G, Scheinert D, Zeller T; Zilver PTX Investigators. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol. 2013;61:2417-2427.
-
(2013)
J Am Coll Cardiol
, vol.61
, pp. 2417-2427
-
-
Dake, M.D.1
Ansel, G.M.2
Jaff, M.R.3
Ohki, T.4
Saxon, R.R.5
Smouse, H.B.6
Snyder, S.A.7
O'leary, E.E.8
Tepe, G.9
Scheinert, D.10
Zeller, T.11
-
7
-
-
84922393847
-
Clinical trials in peripheral vascular disease: Pipeline and trial designs: An evaluation of the clinicaltrials.gov database
-
Subherwal S, Patel MR, Chiswell K, Tidemann-Miller BA, Jones WS, Conte MS, White CJ, Bhatt DL, Laird JR, Hiatt WR, Tasneem A, Califf RM. Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the clinicaltrials.gov database. Circulation. 2014;130:1812-1819.
-
(2014)
Circulation
, vol.130
, pp. 1812-1819
-
-
Subherwal, S.1
Patel, M.R.2
Chiswell, K.3
Tidemann-Miller, B.A.4
Jones, W.S.5
Conte, M.S.6
White, C.J.7
Bhatt, D.L.8
Laird, J.R.9
Hiatt, W.R.10
Tasneem, A.11
Califf, R.M.12
-
8
-
-
85028216977
-
-
Miami, FL: Miami Herald. Accessed September 1, 2014
-
Cohen H. "American Idol" finalist Michael Johns dies at 35. Miami, FL: Miami Herald. http://www.miamiherald.com/2014/08/04/4271638/american-idol-finalist-michael.html. Accessed September 1, 2014.
-
"american Idol" Finalist Michael Johns Dies at 35
-
-
Cohen, H.1
-
9
-
-
83655214994
-
Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: Six-month outcomes from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Trial
-
Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, Reynolds MR, Massaro JM, Lewis BA, Cerezo J, Oldenberg NC, Thum CC, Goldberg S, Jaff MR, Steffes MW, Comerota AJ, Ehrman J, Treat- Jacobson D, Walsh ME, Collins T, Badenhop DT, Bronas U, Hirsch AT. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Trial. Circulation. 2012;125:130-139.
-
(2012)
Circulation
, vol.125
, pp. 130-139
-
-
Murphy, T.P.1
Cutlip, D.E.2
Regensteiner, J.G.3
Mohler, E.R.4
Cohen, D.J.5
Reynolds, M.R.6
Massaro, J.M.7
Lewis, B.A.8
Cerezo, J.9
Oldenberg, N.C.10
Thum, C.C.11
Goldberg, S.12
Jaff, M.R.13
Steffes, M.W.14
Comerota, A.J.15
Ehrman, J.16
Treat- Jacobson, D.17
Walsh, M.E.18
Collins, T.19
Badenhop, D.T.20
Bronas, U.21
Hirsch, A.T.22
more..
-
10
-
-
54949131747
-
The prevention of progression of arterial disease and diabetes (POPADAD) trial: Factorial randomized placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
-
Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R, Lee R, Bancroft J, MacEwan S, Shepherd J, Macfarlane P, Morris A, Jung R, Kelly C, Connacher A, Peden N, Jamieson A, Matthews D, Leese G, McKnight J, O'Brien I, Semple C, Petrie J, Gordon D, Pringle S, MacWalter R. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomized placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ. 2008;337:1-10.
-
(2008)
BMJ
, vol.337
, pp. 1-10
-
-
Belch, J.1
Maccuish, A.2
Campbell, I.3
Cobbe, S.4
Taylor, R.5
Prescott, R.6
Lee, R.7
Bancroft, J.8
Macewan, S.9
Shepherd, J.10
Macfarlane, P.11
Morris, A.12
Jung, R.13
Kelly, C.14
Connacher, A.15
Peden, N.16
Jamieson, A.17
Matthews, D.18
Leese, G.19
McKnight, J.20
O'brien, I.21
Semple, C.22
Petrie, J.23
Gordon, D.24
Pringle, S.25
Macwalter, R.26
more..
-
11
-
-
84867405339
-
Comparison of lipid control in patients with coronary versus peripheral artery disease following the first vascular intervention
-
Pereg D, Neuman Y, Elis A, Minha S, Mosseri M, Segev D, Lishner M, Hermoni D. Comparison of lipid control in patients with coronary versus peripheral artery disease following the first vascular intervention. Am J Cardiol. 2012;110:1266-1269.
-
(2012)
Am J Cardiol
, vol.110
, pp. 1266-1269
-
-
Pereg, D.1
Neuman, Y.2
Elis, A.3
Minha, S.4
Mosseri, M.5
Segev, D.6
Lishner, M.7
Hermoni, D.8
-
12
-
-
85028192647
-
-
Accessed September 1, 2014
-
Krisher T. GM says almost-driverless coming by 2020. http://finance.yahoo.com/news/gm-says-almost-driverless-cars-coming-2020-195341672.html. Accessed September 1, 2014.
-
GM Says Almost-driverless Coming by 2020
-
-
Krisher, T.1
|